{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.114222.4.11.7239",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2020-09-15T10:30:47.000-04:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "CDC NHSN Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2022-12-15"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2020-09-15"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7239",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.114222.4.11.7239"
  }],
  "version" : "20200807",
  "name" : "NHSNContraindicationType",
  "title" : "NHSNContraindicationType",
  "status" : "active",
  "experimental" : false,
  "date" : "2020-08-07T01:00:29-04:00",
  "publisher" : "CDC NHSN",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: NHSN surveillance reporting: Contraindication for using chlorhexidine gluconate (CHG) for Central Line Insertion Practices (CLIP) adherence monitoring),(Data Element Scope: A coded observation value representing the type of contraindication.),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "compose" : {
    "include" : [{
      "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
      "concept" : [{
        "code" : "6131-7",
        "display" : "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age"
      },
      {
        "code" : "6132-5",
        "display" : "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use"
      },
      {
        "code" : "6133-3",
        "display" : "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:d4e45d7c-c61b-43c8-8361-b5b5907178e3",
    "timestamp" : "2023-09-26T12:02:12-04:00",
    "total" : 3,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
      "version" : "2023-04",
      "code" : "6131-7",
      "display" : "Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age"
    },
    {
      "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
      "version" : "2023-04",
      "code" : "6132-5",
      "display" : "Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use"
    },
    {
      "system" : "https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html",
      "version" : "2023-04",
      "code" : "6133-3",
      "display" : "Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use"
    }]
  }
}